These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 502645)

  • 21. [Effect of the host on the phase transformations of an influenza virus population].
    Skripchenko GS; Vlasova AG; Rybakova TM
    Vestn Akad Med Nauk SSSR; 1983; (5):28-34. PubMed ID: 6868801
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigenic variation of influenza A (H3N2) virus in relation to influenza epidemics in Shanghai (1968-1977).
    Shen FZ; Wang MH
    Chin Med J (Engl); 1985 Feb; 98(2):83-8. PubMed ID: 3922694
    [No Abstract]   [Full Text] [Related]  

  • 23. [Universal influenza vaccine still far in the future].
    Rimmelzwaan GF; Osterhaus AD
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2305-7. PubMed ID: 10589217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of phagocytosis of the influenza virus by guinea pig alveolar macrophages. II. Effects of phagocytosis of the influenza virus on cellular metabolism].
    Guillaume J; Wattel F; Macke-Van-Moorleghem C; Aerts C; Voisin C
    Ann Inst Pasteur Lille; 1965; 16():11-5. PubMed ID: 5869279
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for macrophage C3d-receptor active in phagocytosis.
    Wellek B; Hahn HH; Opferkuch W
    J Immunol; 1975 May; 114(5):1643-5. PubMed ID: 1123547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States.
    Vincent AL; Swenson SL; Lager KM; Gauger PC; Loiacono C; Zhang Y
    Vet Microbiol; 2009 May; 137(1-2):51-9. PubMed ID: 19203846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vaccinating effect of conjugates of influenza virus surface antigens with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Dokl Akad Nauk SSSR; 1984; 277(3):752-5. PubMed ID: 6489120
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of LS 7500 counter (Beckman) for measurement of phagocytosis of 14C labeled bacteria.
    Steuden W
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):569-72. PubMed ID: 3296996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage dependency of in vitro B cell response to influenza virus antigens.
    McLaren C; Pope B
    J Immunol; 1980 Dec; 125(6):2679-84. PubMed ID: 6968792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of protein and DNA synthesis assays of guinea pig spleen lymphocytes after stimulation with influenza virus antigen and phytohemagglutinin.
    Süss J; Stelzner A; Vogt KH; Schmidt J
    Exp Pathol (Jena); 1979; 17(7-8):498-512. PubMed ID: 510459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of formalin on antigenic properties of influenza virus].
    Zgorzelska K; Wilczyński J
    Med Dosw Mikrobiol; 1980; 32(2):103-11. PubMed ID: 7464350
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influenza A(H1N1) virus drift; alteration of the influenza vaccine for the 1986/'87 season].
    Masurel N; Beyer WE
    Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1929-30. PubMed ID: 2430197
    [No Abstract]   [Full Text] [Related]  

  • 34. [Incorporation of influenza virus antigens into the envelope of the avian oncornavirus].
    Migunova BV; Kuznetsov OK
    Vopr Onkol; 1981; 27(10):63-7. PubMed ID: 6272489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indication and study of antigenic properties of influenza virus internal proteins by means of monoclonal antibodies.
    Trushinskaya GN; Ivanova VT; Russ G; Poláková K; Isachenko VA; Zakstelskaya LA
    Acta Virol; 1985 Sep; 29(5):428-31. PubMed ID: 2866699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological and epidemiological aspects of the persistence of the influenza virus].
    Golubev DB; Medvedeva MN
    Vestn Akad Med Nauk SSSR; 1983; (5):34-9. PubMed ID: 6868803
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic variation of recent influenza A(H1N1) viruses.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(32):510-2. PubMed ID: 3090423
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of isoprinosine (ISO) on some cell immunity parameters in mice infected with influenza viruses and in mixed viral-bacterial infections. II. Phagocytosis and bactericidal activity of granulocytes.
    Kowalska M; Denys A; Szydłowska T; Białek J
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):741-53. PubMed ID: 2421685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo longitudinal analysis of a dominant TCR repertoire selected in human response to influenza virus.
    Prevost-Blondel A; Lengagne R; Letourneur F; Pannetier C; Gomard E; Guillet JG
    Virology; 1997 Jun; 233(1):93-104. PubMed ID: 9201219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.